RXRX Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Recursion Pharmaceuticals Inc

Watchlist Manager

Watchlist

Price: 3.23 USD 3.86% Market Closed

Market Cap: $1.7B

	Recursion Pharmaceuticals Inc NASDAQ:RXRX	US
D	Derichebourg SA XMUN:PNU	FR
	Compagnie Generale des Etablissements Michelin SCA OTC:MGDDF	FR

Profitability Summary

Recursion Pharmaceuticals Inc's profitability score is 14/100. We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Low Gross Margin

Low 3Y Average Gross Margin

Gross Margin is Increasing

-13% > 7%

Negative Operating Margin

-881%

Negative 3Y Average Operating Margin

-865%

Declining Operating Margin

-548% > -881%

Negative Net Margin

-843%

Negative 3Y Average Net Margin

-839%

Declining Net Margin

-534% > -843%

Negative Free Cash Flow Margin

-491%

Negative 3Y Average Free Cash Flow Margin

-636%

Free Cash Flow Margin is Increasing

-583% > -491%

Negative ROE

-57%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-130%

ROIC is Increasing

-177% > -80%

View All

Hide

Collapse

14 / 100

Profitability
Score

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.